Thanks to the news about another potentially effective vaccine against the lung disease Covid-19, the Dow Jones Industrial could cracked the round mark of 30,000 points on Monday for the first time in its 124-year history. The broker IG valued the US leading index about an hour before the start, 1.69 percent higher to 29 977 points. Wall Street had already shown its strong side last week.
With the pharmaceutical company Moderna Another manufacturer presented promising data for its corona vaccine. The vaccine had an effectiveness of 94.5 percent, it said in a statement from Moderna. In addition, it became known that the European Medicines Agency Ema is starting a so-called rolling review process for the Moderna vaccine, which aims to achieve comparatively fast approval. Moderna shares soared in pre-market US trading by a good twelve percent.
The apparently effective vaccine from Moderna can be stored for a comparatively long time at normal refrigerator temperature. The vaccine from the manufacturer Pfizer and its German partner Biontech however, it must be transported frozen at around minus 70 degrees to the location of the vaccination. The two companies had already presented positive data last week and thus spurred stock exchanges around the world. Pfizer’s papers went down 1.9 percent before the IPO and Biontech’s fell 7.5 percent.
Otherwise, takeovers are the focus at the beginning of the week. This is what the major Spanish bank BBVA wants its US business to the PNC Financial Services Group to sell. Their shares gained around three percent before the market.
Home Depot DIY chain wants the wholesaler HD Supply to swallow. Its shares soared by around 24 percent before the market, while those of Home Depot rose by 0.6 percent./la/fba
ISIN US2605661048 US6311011026 US78378X1072
AXC0269 2020-11-16/14:54
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
– .
